Literature DB >> 32150326

Cancer stem cell enrichment is associated with enhancement of nicotinamide N-methyltransferase expression.

Valentina Pozzi1,2, Eleonora Salvolini1, Guendalina Lucarini3, Alessia Salvucci1, Roberto Campagna1, Corrado Rubini4, Davide Sartini1, Monica Emanuelli1,2.   

Abstract

The cancer stem cell theory states that a subset of tumor cells, termed cancer stem cells (CSCs), has the ability to self-renew and differentiate within the tumors. According to this theory, CSCs would be mainly responsible for tumor initiation, progression, resistance to therapy, recurrence, and metastasis. In this study, a culture system was setup to enrich CSCs from bladder cancer (T24), lung cancer (A549), colorectal cancer (CaCo-2), and osteosarcoma (MG63) cell lines, through sphere formation. Magnetic-activated cell sorting was also used to further increase CSC enrichment. Subsequently, molecular characterization of CSC-enriched cell populations and parental cells was carried out, by exploring the expression levels of stem markers and the enzyme nicotinamide N-methyltransferase (NNMT). Results obtained showed a significant upregulation of stem cell markers in CSC-enriched populations, obtained upon sphere formation, compared with parental counterparts. Moreover, NNMT expression levels were markedly increased in samples enriched with CSCs with respect to control cells. Considering the fundamental role played by CSCs in carcinogenesis, reported data strengthen the hypothesis that sustains a pivotal role of NNMT in cancer growth and metastasis. In addition, these findings could represent an important achievement for the development of new and effective anticancer therapies, based on CSC-associated targets.
© 2020 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  cancer stem cells; gene expression analysis; magnetic-activated cell sorting; molecular characterization; nicotinamide N-methyltransferase; sphere-forming cells

Year:  2020        PMID: 32150326     DOI: 10.1002/iub.2265

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  11 in total

Review 1.  Nicotinamide N-Methyltransferase: An Emerging Protagonist in Cancer Macro(r)evolution.

Authors:  Richard B Parsons; Paul D Facey
Journal:  Biomolecules       Date:  2021-09-28

2.  Methyl Donors Reduce Cell Proliferation by Diminishing Erk-Signaling and NFkB Levels, While Increasing E-Cadherin Expression in Panc-1 Cell Line.

Authors:  Eva Kiss; Gertrud Forika; Magdolna Dank; Tibor Krenacs; Zsuzsanna Nemeth
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

Review 3.  Sulforaphane and Its Bifunctional Analogs: Synthesis and Biological Activity.

Authors:  Łukasz Janczewski
Journal:  Molecules       Date:  2022-03-07       Impact factor: 4.411

Review 4.  High Risk-Human Papillomavirus in HNSCC: Present and Future Challenges for Epigenetic Therapies.

Authors:  Lavinia Ghiani; Susanna Chiocca
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

Review 5.  Potential Therapeutic Effects of PPAR Ligands in Glioblastoma.

Authors:  Rossella Basilotta; Marika Lanza; Giovanna Casili; Giulia Chisari; Stefania Munao; Lorenzo Colarossi; Laura Cucinotta; Michela Campolo; Emanuela Esposito; Irene Paterniti
Journal:  Cells       Date:  2022-02-10       Impact factor: 6.600

Review 6.  Predicting Response to Neoadjuvant Therapy in Oesophageal Adenocarcinoma.

Authors:  William Jiang; Jelske M de Jong; Richard van Hillegersberg; Matthew Read
Journal:  Cancers (Basel)       Date:  2022-02-16       Impact factor: 6.639

Review 7.  Biological evidence of cancer stem-like cells and recurrent disease in osteosarcoma.

Authors:  Camille Jubelin; Javier Muñoz-Garcia; Denis Cochonneau; Emilie Moranton; Marie-Françoise Heymann; Dominique Heymann
Journal:  Cancer Drug Resist       Date:  2022-02-16

Review 8.  The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches.

Authors:  Monica Emanuelli; Davide Sartini; Elisa Molinelli; Roberto Campagna; Valentina Pozzi; Eleonora Salvolini; Oriana Simonetti; Anna Campanati; Annamaria Offidani
Journal:  Antioxidants (Basel)       Date:  2022-03-23

Review 9.  Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy.

Authors:  Xiao-Yu Li; Ya-Nan Pi; Yao Chen; Qi Zhu; Bai-Rong Xia
Journal:  Front Oncol       Date:  2022-06-09       Impact factor: 5.738

Review 10.  Complex roles of nicotinamide N-methyltransferase in cancer progression.

Authors:  Weixuan Wang; Changmei Yang; Tianxiang Wang; Haiteng Deng
Journal:  Cell Death Dis       Date:  2022-03-25       Impact factor: 9.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.